Skip to main content
Top
Published in: Trials 1/2020

Open Access 01-12-2020 | Iron Deficiency | Study protocol

Ferritin measurement IN Donors—Effectiveness of iron Monitoring to diminish iron deficiency and low haemoglobin in whole blood donors (FIND’EM): study protocol for a stepped wedge cluster randomised trial

Authors: Maike G. Sweegers, Saurabh Zalpuri, Franke A. Quee, Elisabeth M. J. Huis in ‘t Veld, Femmeke J. Prinsze, Emiel O. Hoogendijk, Jos W. R. Twisk, Anton W. M. van Weert, Wim L. A. M. de Kort, Katja van den Hurk

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Blood donors are at risk for reduced iron stores, because of which donor iron monitoring received increased attention in the last decade. Despite the importance for donor health, international consensus on an appropriate policy for iron monitoring is lacking. Therefore, we conduct a trial to evaluate to what extent ferritin-guided donation intervals are effective in increasing haemoglobin and ferritin levels, decreasing low-haemoglobin deferral, increasing donor return and improving the health of whole blood donors in the Netherlands.

Methods

Sanquin Blood Bank is implementing ferritin-guided donation intervals to prevent donors from increasing iron loss at repeated donations. Using a stepped wedge cluster randomised trial approach, the design involves a random crossover of 29 clusters of blood collection centres from the existing policy without ferritin measurements to a ferritin-guided donation interval policy. This new policy includes ferritin measurements for all new donors and at every 5th whole blood donation, extending donation intervals to 6 months if ferritin is 15–≤ 30 ng/mL and to 12 months if ferritin is < 15 ng/mL. We measure ferritin levels of whole blood donors from stored plasma samples and collect haemoglobin levels and information on low-haemoglobin deferral and donor return from the donor database before, during and after the implementation period. We measure donor health during and after the implementation period using questionnaires, assessing physical and mental wellbeing and iron deficiency- and donation-related symptoms. We use multilevel analyses to investigate differences in ferritin and haemoglobin levels, low-haemoglobin deferral rates, donor return and donor health from whole blood donors, between blood collection centres that have versus those that have not yet implemented the ferritin-guided donation interval policy.

Discussion

This stepped wedge cluster randomised trial will provide insight into the effectiveness of ferritin-guided donation intervals in lowering iron deficiency, decreasing donor deferrals due to low haemoglobin and improving donor health. We will evaluate a policy that is implemented nationwide in a real-life setting. Our study is therefore not limited to a small experimental setting and the results will guide policymakers seeking an appropriate policy for iron monitoring.

Trial registration

The Dutch trial registry NTR6738. Registered on 29 September 2017. Retrospectively registered.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brittenham GM. Iron balance in the red blood cell donor. Dev Biol (Basel). 2005;120:77–82. Brittenham GM. Iron balance in the red blood cell donor. Dev Biol (Basel). 2005;120:77–82.
2.
go back to reference Boulton F. Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med. 2008;18(1):13–27.CrossRef Boulton F. Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med. 2008;18(1):13–27.CrossRef
3.
go back to reference Newman B. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion. 2006;46(10):1667–81.CrossRef Newman B. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion. 2006;46(10):1667–81.CrossRef
4.
go back to reference Spencer B. Blood donor iron status: are we bleeding them dry? Curr Opin Hematol. 2013;20(6):533–9.CrossRef Spencer B. Blood donor iron status: are we bleeding them dry? Curr Opin Hematol. 2013;20(6):533–9.CrossRef
5.
go back to reference Schotten N, Pasker-de Jong PC, Moretti D, Zimmermann MB, Geurts-Moespot AJ, Swinkels DW, et al. The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism. Blood. 2016;128(17):2185–8.CrossRef Schotten N, Pasker-de Jong PC, Moretti D, Zimmermann MB, Geurts-Moespot AJ, Swinkels DW, et al. The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism. Blood. 2016;128(17):2185–8.CrossRef
6.
go back to reference Moore C, Sambrook J, Walker M, Tolkien Z, Kaptoge S, Allen D, et al. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials. 2014;15:363.CrossRef Moore C, Sambrook J, Walker M, Tolkien Z, Kaptoge S, Allen D, et al. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials. 2014;15:363.CrossRef
7.
go back to reference Dijkstra A, van den Hurk K, Bilo HJG, Slingerland RJ, Vos MJ. Repeat whole blood donors with a ferritin level of 30 mug/L or less show functional iron depletion. Transfusion. 2019;59(1):21–5.CrossRef Dijkstra A, van den Hurk K, Bilo HJG, Slingerland RJ, Vos MJ. Repeat whole blood donors with a ferritin level of 30 mug/L or less show functional iron depletion. Transfusion. 2019;59(1):21–5.CrossRef
8.
go back to reference Di Angelantonio E, Thompson SG, Kaptoge S, Moore C, Walker M, Armitage J, et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors. Lancet. 2017;390(10110):2360–71.CrossRef Di Angelantonio E, Thompson SG, Kaptoge S, Moore C, Walker M, Armitage J, et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors. Lancet. 2017;390(10110):2360–71.CrossRef
9.
go back to reference Boulton F. Managing donors and iron deficiency. Vox Sang. 2004;87(Suppl 2):22–4.CrossRef Boulton F. Managing donors and iron deficiency. Vox Sang. 2004;87(Suppl 2):22–4.CrossRef
10.
go back to reference Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood. 2003;101(9):3359–64.CrossRef Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood. 2003;101(9):3359–64.CrossRef
11.
go back to reference WHO. Guidelines on assessing donor suitability for blood donation. blood donor selection. Geneva: World Health Organisation; Guidelines Approved by the Guidelines Review Committee; 2012. WHO. Guidelines on assessing donor suitability for blood donation. blood donor selection. Geneva: World Health Organisation; Guidelines Approved by the Guidelines Review Committee; 2012.
12.
go back to reference Alvarez-Ossorio L, Kirchner H, Kluter H, Schlenke P. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfus Med. 2000;10(2):107–12.CrossRef Alvarez-Ossorio L, Kirchner H, Kluter H, Schlenke P. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfus Med. 2000;10(2):107–12.CrossRef
13.
go back to reference Baart AM, van den Hurk K, de Kort WL. Minimum donation intervals should be reconsidered to decrease low hemoglobin deferral in whole blood donors: an observational study. Transfusion. 2015;55(11):2641–4.CrossRef Baart AM, van den Hurk K, de Kort WL. Minimum donation intervals should be reconsidered to decrease low hemoglobin deferral in whole blood donors: an observational study. Transfusion. 2015;55(11):2641–4.CrossRef
14.
go back to reference Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391.CrossRef Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391.CrossRef
15.
go back to reference European Directorate for the Quality of Medicines and HealthCare. Guide for the preparation, use and quality assurance of blood components. Councel Eur. 2015. European Directorate for the Quality of Medicines and HealthCare. Guide for the preparation, use and quality assurance of blood components. Councel Eur. 2015.
16.
go back to reference Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med. 2009;47(5):596–603.CrossRef Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med. 2009;47(5):596–603.CrossRef
17.
go back to reference Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRef Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRef
18.
go back to reference Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–92.CrossRef Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–92.CrossRef
19.
go back to reference Van den Hurk K, Peffer K, Habets K, Atsma F, Pasker-de Jong PCM, Van Noord PAH, et al. Blood donors’ physical characteristics are associated with pre- and post-donation symptoms - Donor InSight. Blood Transfus. 2017;15(5):405–12.PubMedCentral Van den Hurk K, Peffer K, Habets K, Atsma F, Pasker-de Jong PCM, Van Noord PAH, et al. Blood donors’ physical characteristics are associated with pre- and post-donation symptoms - Donor InSight. Blood Transfus. 2017;15(5):405–12.PubMedCentral
20.
go back to reference Ferguson E, Atsma F, de Kort W, Veldhuizen I. Exploring the pattern of blood donor beliefs in first-time, novice, and experienced donors: differentiating reluctant altruism, pure altruism, impure altruism, and warm glow. Transfusion. 2012;52(2):343–55.CrossRef Ferguson E, Atsma F, de Kort W, Veldhuizen I. Exploring the pattern of blood donor beliefs in first-time, novice, and experienced donors: differentiating reluctant altruism, pure altruism, impure altruism, and warm glow. Transfusion. 2012;52(2):343–55.CrossRef
21.
go back to reference Dreischulte T, Grant A, Donnan P, Guthrie B. Pro’s and con’s of the stepped wedge design in cluster randomised trials of quality improvement interventions: two current examples. Trials. 2013;14(Suppl 1):O87.CrossRef Dreischulte T, Grant A, Donnan P, Guthrie B. Pro’s and con’s of the stepped wedge design in cluster randomised trials of quality improvement interventions: two current examples. Trials. 2013;14(Suppl 1):O87.CrossRef
22.
go back to reference Caille A, Kerry S, Tavernier E, Leyrat C, Eldridge S, Giraudeau B. Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials. BMJ. 2016;354:i4291.CrossRef Caille A, Kerry S, Tavernier E, Leyrat C, Eldridge S, Giraudeau B. Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials. BMJ. 2016;354:i4291.CrossRef
23.
go back to reference Hemming K, Taljaard M. Sample size calculations for stepped wedge and cluster randomised trials: a unified approach. J Clin Epidemiol. 2016;69:137–46.CrossRef Hemming K, Taljaard M. Sample size calculations for stepped wedge and cluster randomised trials: a unified approach. J Clin Epidemiol. 2016;69:137–46.CrossRef
24.
go back to reference Magnussen K, Ladelund S. Handling low hemoglobin and iron deficiency in a blood donor population: 2 years’ experience. Transfusion. 2015;55(10):2473–8.CrossRef Magnussen K, Ladelund S. Handling low hemoglobin and iron deficiency in a blood donor population: 2 years’ experience. Transfusion. 2015;55(10):2473–8.CrossRef
Metadata
Title
Ferritin measurement IN Donors—Effectiveness of iron Monitoring to diminish iron deficiency and low haemoglobin in whole blood donors (FIND’EM): study protocol for a stepped wedge cluster randomised trial
Authors
Maike G. Sweegers
Saurabh Zalpuri
Franke A. Quee
Elisabeth M. J. Huis in ‘t Veld
Femmeke J. Prinsze
Emiel O. Hoogendijk
Jos W. R. Twisk
Anton W. M. van Weert
Wim L. A. M. de Kort
Katja van den Hurk
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Iron Deficiency
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04648-w

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue